lactic acid and lexipafant

lactic acid has been researched along with lexipafant in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cabral, A; Rogiers, P; Spapen, H; Verhaeghe, V; Vincent, JL; Zhang, H	1
Bakker, J; Curtis, L; Spapen, H; Vincent, JL; Webster, NR	1

Trials

1 trial(s) available for lactic acid and lexipafant

Article	Year
Phase II multicenter clinical study of the platelet-activating factor receptor antagonist BB-882 in the treatment of sepsis. Critical care medicine, 2000, Volume: 28, Issue:3 Topics: Adult; Aged; Aged, 80 and over; APACHE; Cytokines; Double-Blind Method; Europe; Female; Hemodynamics; Humans; Immunotherapy; Infusions, Intravenous; Lactic Acid; Leucine; Male; Middle Aged; Multiple Organ Failure; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Respiratory Function Tests; Sepsis; Survival Analysis	2000

Article

Year

Phase II multicenter clinical study of the platelet-activating factor receptor antagonist BB-882 in the treatment of sepsis.

Critical care medicine, 2000, Volume: 28, Issue:3

Topics: Adult; Aged; Aged, 80 and over; APACHE; Cytokines; Double-Blind Method; Europe; Female; Hemodynamics; Humans; Immunotherapy; Infusions, Intravenous; Lactic Acid; Leucine; Male; Middle Aged; Multiple Organ Failure; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Respiratory Function Tests; Sepsis; Survival Analysis

2000

Other Studies

1 other study(ies) available for lactic acid and lexipafant

Article	Year
Treatment with a platelet-activating factor antagonist has little protective effects during endotoxic shock in the dog. Shock (Augusta, Ga.), 1997, Volume: 8, Issue:3 Topics: Animals; Dogs; Endotoxins; Female; Hemodynamics; Hemoglobins; Lactic Acid; Leucine; Male; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Regional Blood Flow; Resuscitation; Shock, Septic; Time Factors	1997

Article

Year

Treatment with a platelet-activating factor antagonist has little protective effects during endotoxic shock in the dog.

Shock (Augusta, Ga.), 1997, Volume: 8, Issue:3

Topics: Animals; Dogs; Endotoxins; Female; Hemodynamics; Hemoglobins; Lactic Acid; Leucine; Male; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Regional Blood Flow; Resuscitation; Shock, Septic; Time Factors

1997